Key result
LVEF <55% is linked to ~144% higher mortality in asymptomatic severe aortic stenosis under conservative management.
Why the study?
No data are available concerning the prognostic value of LVEF in asymptomatic or minimally symptomatic severe AS patients with preserved LVEF (≥50%) to identify a threshold associated with increased mortality.
Does an LVEF <55% predict increased mortality compared to LVEF ≥60% in asymptomatic or minimally symptomatic patients with severe aortic stenosis?
Cohort (n=1,678)
Does an LVEF <55% predict increased mortality compared to LVEF ≥60% in asymptomatic or minimally symptomatic patients with severe aortic stenosis?
In asymptomatic or minimally symptomatic patients with severe aortic stenosis, an LVEF <55% is a marker of poor outcome, suggesting these patients should be considered for surgery before reaching the traditional <50% threshold.
Answers are grounded in this paper and cite their sources.
LVEF <55% flags higher mortality risk under conservative management in asymptomatic severe AS; hypothesis-generating for revised intervention thresholds pending prospective trials.
OBJECTIVES: This study sought to determine the best left ventricular ejection fraction (LVEF) cutoff value to predict long-term mortality in patients with asymptomatic or minimally symptomatic severe aortic stenosis (AS) and LVEF ≥50% under conservative management and after surgical correction of AS. BACKGROUND: Aortic valve replacement (AVR) is a Class I indication in asymptomatic patients with severe AS and LVEF <50%. However, this is an uncommon situation in asymptomatic severe AS (<1% of patients), usually occurring late in the course of the disease. No data are available concerning the prognostic value of LVEF in asymptomatic or minimally symptomatic AS patients with preserved LVEF (≥50%) in order to identify a LVEF threshold value associated with increased mortality. METHODS: This analysis included 1,678 patients with preserved LVEF and no or minimal symptoms, with a diagnosis of severe AS. The population was divided into 3 groups: LVEF <55%, LVEF 55% to 59%, and LVEF ≥60%. RESULTS: Five-year survival rate was 72 ± 2% for patients with LVEF ≥60%, 74 ± 2% for patients with LVEF between 55% and 59%, and 59 ± 4% for patients with LVEF <55% (p < 0.001). Under initially conservative or initially surgical management (surgery within 3 months after baseline echocardiography), patients with LVEF <55% displayed significant excess mortality compared to patients with LVEF≥ 60% (adjusted hazard ratio [HR]: 2.44 [95% confidence interval: 1.51 to 3.94]; p < 0.001 and 2.51 [95% confidence interval: 1.58 to 4.00]; p < 0.001, respectively), whereas patients with LVEF between 55% and 59% had comparable prognosis to those with LVEF ≥60% (p = 0.53 and p = 0.36, respectively). In patients with LVEF <55%, initial conservative management was associated with increased mortality compared to initial surgical management, even after covariate adjustment (adjusted hazard ratio [HR]: 2.70 [95% confidence interval: 1.98 to 3.67]; p < 0.001). CONCLUSIONS: In patients with severe AS, preserved LVEF and no or minimal symptoms at the time of diagnosis, LVEF <55% is a marker of poor outcome, with medical or surgical management suggesting that these patients should be considered for surgery before this stage.
No takes yet. Share an insight, caveat, or question.
Bohbot et al. (2018) conducted a cohort in Severe aortic stenosis (n=1,678). LVEF <55% vs. LVEF ≥60% was evaluated on 5-year survival rate (HR 2.44, 95% CI 1.51 to 3.94, p=<0.001). In asymptomatic severe aortic stenosis, LVEF <55% was associated with higher mortality compared to LVEF ≥60% under conservative management.
Synapse has enriched 10 related papers. Consider them for comparative context: